Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25947174 | 0.91 | DNM1 (0.33) | DNM1 | |
| SCHEMBL25947092 | 0.80 | DNM1 (0.41) | DNM1 | |
| SCHEMBL14157686 | 0.77 | DNM1 (0.65) | DNM1 | |
| Oxalic Acid SCHEMBL30307028 | 0.74 | DNM1 (0.60) | DNM1 | |
| SCHEMBL9480399 | 0.74 | DNM1 (0.56) | DNM1 | |
| SCHEMBL24144847 | 0.73 | CHRM5 (0.38) | DNM1 | |
| SCHEMBL17586414 | 0.72 | DNM1 (0.53) | DNM1 | |
| SCHEMBL21467209 | 0.72 | DNM1 (0.53) | DNM1 | |
| SCHEMBL14239733 | 0.72 | DNM1 (0.56) | DNM1 | |
| SCHEMBL25947141 | 0.71 | MMP8 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230250056-A1 | PROCESS FOR SYNTHESIZING LIPIDS | BRISTOL-MYERS SQUIBB COMPANY | 2023-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230250056-A1 | PROCESS FOR SYNTHESIZING LIPIDS | PLIN1, SREBF1, SREBF2 | DNM1 1086/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.